Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopecia

Investigating the safety and efficacy of intradermal injection of autologous Nanofat and conditioned medium derived from Wharton jelly mesenchymal stem cells in the treatment of androgenic alopecia compared to Nanofat alone: a double-blind clinical trial study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N34

Enrollment

Registered

2024-05-25

Start date

2024-06-04

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention 1: Intervention group: One side of the head nanofat and condition medium is injected once. Intervention 2: Control group: One side of the head of nanofet and normal salineis injected once

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age between 18-60 Patients who do not want to take or are allergic to minoxidil

Exclusion criteria

Exclusion criteria: Individuals who have used any product or medication during the previous 6 months that may affect hair growth Pregnancy and breastfeeding History of cancer People with Mental Disorders Active infection of the scalp

Design outcomes

Primary

Measure	Time frame
The amount of hair loss. Timepoint: Before treatment and one month after the last session. Method of measurement: Trichoscan.	—

Secondary

Measure	Time frame
Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026